Core Viewpoint - The announcement from Maide Medical indicates a delay in the completion of its project due to various operational adjustments, which may impact future production timelines and investor sentiment [1]. Group 1: Company Performance - As of October 27, 2025, Maide Medical's stock closed at 21.03 yuan, reflecting a 0.62% increase from the previous trading day [1]. - The company's total market capitalization is reported at 3.496 billion yuan [1]. - The stock opened at 20.88 yuan, reached a high of 21.44 yuan, and a low of 20.71 yuan, with a trading volume of 48.8183 million yuan and a turnover rate of 1.4% [1]. Group 2: Project Update - Maide Medical announced the use of 64.2129 million yuan of raised funds for the "Annual Production of 35 Medical Equipment Combination Intelligent Equipment Expansion Project" [1]. - Due to production layout adjustments, construction optimization, and equipment procurement and installation challenges, the project’s expected operational date has been postponed from November 2025 to November 2026 [1]. - This decision has been approved by the company's board of directors and supervisory board, with no objections from the sponsor, GF Securities Co., Ltd. [1].
迈得医疗(688310)披露募投项目延期公告,10月27日股价上涨0.62%